Grants per year
Search results
-
Active
AALL0434: Intensified Methotrexate, Nelarabine (Compound 506U78; IND#52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL) or T-cell Lymphoblastic Lymphoma
Morgan, E. R. (PD/PI)
Children’s Hospital of Philadelphia, Novartis Pharmaceuticals Corporation
10/3/19 → 8/31/50
Project: Research project